221 related articles for article (PubMed ID: 19235683)
1. Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design.
Evidente A; Kireev AS; Jenkins AR; Romero AE; Steelant WF; Van Slambrouck S; Kornienko A
Planta Med; 2009 Apr; 75(5):501-7. PubMed ID: 19235683
[TBL] [Abstract][Full Text] [Related]
2. The effect of Amaryllidaceae alkaloids haemanthamine and haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells.
Havelek R; Seifrtova M; Kralovec K; Bruckova L; Cahlikova L; Dalecka M; Vavrova J; Rezacova M; Opletal L; Bilkova Z
Phytomedicine; 2014 Mar; 21(4):479-90. PubMed ID: 24182986
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae.
Nair JJ; Rárová L; Strnad M; Bastida J; van Staden J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6195-9. PubMed ID: 22921081
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic agents of the crinane series of amaryllidaceae alkaloids.
Nair JJ; Bastida J; Viladomat F; van Staden J
Nat Prod Commun; 2012 Dec; 7(12):1677-88. PubMed ID: 23413581
[TBL] [Abstract][Full Text] [Related]
5. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids.
McNulty J; Nair JJ; Codina C; Bastida J; Pandey S; Gerasimoff J; Griffin C
Phytochemistry; 2007 Apr; 68(7):1068-74. PubMed ID: 17331551
[TBL] [Abstract][Full Text] [Related]
6. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
Van Goietsenoven G; Andolfi A; Lallemand B; Cimmino A; Lamoral-Theys D; Gras T; Abou-Donia A; Dubois J; Lefranc F; Mathieu V; Kornienko A; Kiss R; Evidente A
J Nat Prod; 2010 Jul; 73(7):1223-7. PubMed ID: 20550100
[TBL] [Abstract][Full Text] [Related]
7. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
8. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice.
Havelek R; Muthna D; Tomsik P; Kralovec K; Seifrtova M; Cahlikova L; Hostalkova A; Safratova M; Perwein M; Cermakova E; Rezacova M
Chem Biol Interact; 2017 Sep; 275():121-132. PubMed ID: 28756149
[TBL] [Abstract][Full Text] [Related]
9. Pseudolycorine
Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
Nat Prod Res; 2020 Jul; 34(14):2051-2058. PubMed ID: 30784301
[TBL] [Abstract][Full Text] [Related]
10. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.
Gopalakrishnan R; Matta H; Choi S; Chaudhary PM
Sci Rep; 2020 Mar; 10(1):5712. PubMed ID: 32235878
[TBL] [Abstract][Full Text] [Related]
11. Narciclasine-4-
Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
Nat Prod Res; 2020 Jan; 34(2):233-240. PubMed ID: 30636443
[TBL] [Abstract][Full Text] [Related]
12. Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
McNulty J; Thorat A; Vurgun N; Nair JJ; Makaji E; Crankshaw DJ; Holloway AC; Pandey S
J Nat Prod; 2011 Jan; 74(1):106-8. PubMed ID: 21105682
[TBL] [Abstract][Full Text] [Related]
13. Amaryllidaceae Alkaloids Decrease the Proliferation, Invasion, and Secretion of Clinically Relevant Cytokines by Cultured Human Colon Cancer Cells.
Mathieu V; Laguera B; Masi M; Dulanto SA; Bingham TW; Hernandez LW; Sarlah D; Evidente A; Lafontaine DLJ; Kornienko A; Lane MA
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139106
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Phytochemistry; 2009 May; 70(7):913-9. PubMed ID: 19464034
[TBL] [Abstract][Full Text] [Related]
15. Bulbispermine: a crinine-type Amaryllidaceae alkaloid exhibiting cytostatic activity toward apoptosis-resistant glioma cells.
Luchetti G; Johnston R; Mathieu V; Lefranc F; Hayden K; Andolfi A; Lamoral-Theys D; Reisenauer MR; Champion C; Pelly SC; van Otterlo WA; Magedov IV; Kiss R; Evidente A; Rogelj S; Kornienko A
ChemMedChem; 2012 May; 7(5):815-22. PubMed ID: 22389235
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of alkaloids derived from Amaryllidaceae species.
Zupkó I; Réthy B; Hohmann J; Molnár J; Ocsovszki I; Falkay G
In Vivo; 2009; 23(1):41-8. PubMed ID: 19368123
[TBL] [Abstract][Full Text] [Related]
17. Lycorine and its derivatives for anticancer drug design.
Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L
Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122
[TBL] [Abstract][Full Text] [Related]
18. Anti-SARS-CoV-2 Activity and Cytotoxicity of Amaryllidaceae Alkaloids from
Le NT; De Jonghe S; Erven K; Vermeyen T; Baldé AM; Herrebout WA; Neyts J; Pannecouque C; Pieters L; Tuenter E
Molecules; 2023 Apr; 28(7):. PubMed ID: 37049986
[TBL] [Abstract][Full Text] [Related]
19. In-silico profiling of the biological activities of Amaryllidaceae alkaloids.
Shawky E
J Pharm Pharmacol; 2017 Nov; 69(11):1592-1605. PubMed ID: 28809439
[TBL] [Abstract][Full Text] [Related]
20. Zephgrabetaine: a new betaine-type amaryllidaceae alkaloid from Zephyranthes grandiflora.
Katoch D; Kumar D; Sharma U; Kumar N; Padwad YS; Lal B; Singh B
Nat Prod Commun; 2013 Feb; 8(2):161-4. PubMed ID: 23513717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
